Source-checked routes to capital, grants, awards or commercialization support.
DNA FUTURE · 2026 EDITION
DNA Capital 30
DNA Capital 30 is an independent editorial selection, not a ranking or endorsement, of capital and access pathways for student, young and research-driven founders.
It distinguishes direct investment, non-dilutive funding, competitive awards, program support and capital access. Eligibility, funding certainty and current status are checked against official sources; inclusion does not imply affiliation and does not guarantee admission or funding.
Overlapping founder routes: young, research commercialization and open early capital.
Official sources checked for the 2026 Q4 edition.
CURRENT SELECTION
DNA Capital 30
Q4 2026
Thirty equal-status capital and access pathways for student, young and research-driven founders. Numbers are reference IDs—not rankings.
No.Institution / ProgramBest ForFunding / SupportCurrent StatusWebsite
01Technical students and recent graduates ready to build or join a startupFounder Track: up to $250K; Talent Track carries no fellowship paySource checked · Closed · Deadline passed Oct 11VISIT ↗
02Students planning to start full-time after finishing the current school yearApplication route; accepted companies receive YC's standard $500K investmentSource checked · ApplyVISIT ↗
03People 22 or younger without a university degree$250K over two years · non-dilutiveSource checked · Year-roundVISIT ↗
04Students and nontraditional founders in North America$1K unconditional grant; later VC investment is a separate decisionSource checked · SubmitVISIT ↗
05Current students and recent graduatesEarly direct investment; current check range not standardized publiclySource checked · OpenVISIT ↗
06Pre-seed founders; Competition is a separate student routePearX invests $500K–$2M, targeting about 7%; Competition terms differSource checked · Check current cycleVISIT ↗
07Technical students, early founders and exceptional buildersSeparate paths: student grant, Residency capital and seed investmentSource checked · By pathwayVISIT ↗
08Very early individuals and small teamsPublicly stated $10K support; current page does not specify the instrumentSource checked · RollingVISIT ↗
09Student founders and very early teamsStarter grant + early equity pathway; current amount not fully publishedSource checked · Status uncertain · Cohort TBAVISIT ↗
10Students, recent graduates and very early technical founders$20K–$100K YC-style SAFE; separate $1K Afore GrantsSource checked · Confirm current cohortVISIT ↗
11Cross-university student founders able to attend in San FranciscoPast cohort: $35K uncapped MFN SAFE + 2.5% common equitySource checked · ClosedVISIT ↗
12Software startups led by students, recent grads, postdocs or facultyTypical $250K first check; separate pitch competition uses a $150K SAFESource checked · Status uncertain · Check routeVISIT ↗
13Students, graduate students, postdocs and faculty from any university2025 competition offered cumulative SAFE funding; not a guaranteed awardHistorical source · 2025 closed · 2026 TBAVISIT ↗
14Hard tech, industrial and life-science teamsSeparate accelerator investments; terms vary by programSource checked · By programVISIT ↗
15Experienced scientists and engineers commercializing researchZero-equity fellowship package with living, R&D and travel supportSource checked · ApplyVISIT ↗
16Tough Tech researchers, PhDs and spinout teamsFree commercialization program and investor access; no direct fundingSource checked · Spring 2027 interestVISIT ↗
17Founders building around university and national-lab technologyFree studio; $50K final prize pool is competitive, not guaranteedSource checked · ClosedVISIT ↗
18US university student-led science and engineering teams$5K Pioneer + $20K Propel grants, awarded through US universitiesSource checked · Spring 2027 upcomingVISIT ↗
19Scientists, PhDs and postdoc technology foundersFree 12-week program; no equity, fees or direct program fundingSource checked · 2027 upcomingVISIT ↗
20Scientists and engineers commercializing national-lab technologiesTwo-year funded fellowship with stipend, travel, healthcare and lab supportSource checked · Closes Oct 30VISIT ↗
21Climate biotech and very early research teams2025 historical $50K–$150K research grants; current cycle not openSource checked · 2025 closedVISIT ↗
22Exploration-stage individuals and newly formed teams$400K for 7% SAFE + $600K guaranteed in the next external roundSource checked · Spring 2027 upcomingVISIT ↗
23Individuals ready to found a company before team or idea formationSeparate routes: $10K equity-free fellowship or selective $250K investmentSource checked · Rolling · Investment selectiveVISIT ↗
24Day-zero founders and individuals seeking co-foundersFree residency; direct investment only after committee approvalSource checked · RollingVISIT ↗
25Early companies seeking zero-equity accelerationNo equity or upfront investment; selected challenges offer cash awardsSource checked · Program-dependentVISIT ↗
26First-time founders and pre-seed teamsOpen submission; investment is selective and terms are not standardized publiclySource checked · SubmitVISIT ↗
27Very early and first-time founders; not student-specificSelective early-stage investment + structured founder supportSource checked · Contact onlyVISIT ↗
28Global climate founders aged 18–24$100K over two years · non-dilutive grant; 2026 cohort selectedSource checked · Closed · Next cycle TBAVISIT ↗
29Immigrant, international-student and visa-constrained US foundersFirst check + immigration support; terms not standardized publiclySource checked · OpenVISIT ↗
30US founders addressing education or technology inequityCurrent Apply page states $50K; instrument depends on organization typeSource checked · ClosedVISIT ↗
List reviewed: 13 October 2026 · Each research profile displays its own review date.“Source checked” means supported by first-party information as of the review date; official current terms control.
EDITORIAL POLICY
About
the List
DNA Capital 30 helps student, young and research-driven founders identify source-supported routes to capital and commercialization support. It answers a practical question: which pathways are relevant at a founder’s current stage?
A capital-access directory
Direct investment, non-dilutive funding, competitive awards and commercialization support.
Selected, not ranked
All 30 institutions have equal editorial status. Numbers are reference IDs, not scores.
A documented founder pathway
General mentoring and community programs without a defined capital or commercialization path are excluded.
Three routes that may overlap
Young founder, research commercialization, and open or special-access early capital.
Official sources first
Eligibility, funding relationships, economic terms and status are checked against first-party sources.
Funding is not always automatic
We distinguish standard funding, secondary review, competitive awards and capital access without direct funding.
From candidate pool to final selection
A wider research pool is screened for funding, restrictions, evidence quality and founder relevance.
No pay-to-play inclusion
Sponsorships, partnerships, client relationships and event participation do not influence inclusion.
READ THE LIST WITH CONFIDENCE
How to Read DNA Capital 30
Understand each pathway’s funding type, eligibility, verification level and application status.
→